
Sign up to save your podcasts
Or


Introducing Leading Through Setbacks with Cytokinetics’ Robert Blum from Clinical Trialblazers.
Follow the show: Clinical Trialblazers
In this episode of Clinical Trial Blazers, host Alberto Grignolo speaks with Robert Blum, president and CEO of Cytokinetics, about his journey from the biology classroom to leading a biopharmaceutical company focused on muscle biology. Robert shares the values that guide his leadership style and how to move forward after failing.
DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to [email protected].
By Adam Graham4.8
3737 ratings
Introducing Leading Through Setbacks with Cytokinetics’ Robert Blum from Clinical Trialblazers.
Follow the show: Clinical Trialblazers
In this episode of Clinical Trial Blazers, host Alberto Grignolo speaks with Robert Blum, president and CEO of Cytokinetics, about his journey from the biology classroom to leading a biopharmaceutical company focused on muscle biology. Robert shares the values that guide his leadership style and how to move forward after failing.
DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to [email protected].

1,952 Listeners

192 Listeners

526 Listeners

319 Listeners

272 Listeners

1,048 Listeners

423 Listeners

265 Listeners

381 Listeners

934 Listeners

38 Listeners

427 Listeners

13 Listeners

708 Listeners

401 Listeners

138 Listeners

42 Listeners

11 Listeners

13 Listeners

5 Listeners

6 Listeners

25 Listeners

29 Listeners

9 Listeners

229 Listeners

9 Listeners

176 Listeners

5 Listeners

14 Listeners

35 Listeners

5 Listeners